Bruker (BRKRP) FCF Payout Ratio (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bruker | - | - | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 546.58% |
| Dec 31, 2025 | 125.77% |
| Sep 30, 2025 | -175.05% |
| Jun 30, 2025 | -125.87% |
| Mar 31, 2025 | 233.92% |
| Dec 31, 2024 | -111.25% |
| Sep 30, 2024 | 499.91% |
| Jun 30, 2024 | -101.80% |
| Mar 31, 2024 | 43,400.00% |
| Dec 31, 2023 | -90.25% |
| Sep 30, 2023 | 1,605.81% |
| Jun 30, 2023 | -124.13% |
| Mar 31, 2023 | 119.04% |
| Dec 31, 2022 | -91.38% |
| Sep 30, 2022 | 620.93% |
| Jun 30, 2022 | -194.38% |
| Mar 31, 2022 | 134.27% |
| Dec 31, 2021 | -97.73% |
| Sep 30, 2021 | -72.52% |
| Jun 30, 2021 | 10,371.43% |
| Mar 31, 2021 | 137.65% |
| Dec 31, 2020 | -86.88% |
| Sep 30, 2020 | -54.61% |
| Jun 30, 2020 | -57.31% |
| Mar 31, 2020 | 2,300.00% |
| Dec 31, 2019 | -66.48% |
| Sep 30, 2019 | 120.12% |
| Jun 30, 2019 | -148.65% |
| Sep 30, 2018 | -414.93% |
| Jun 30, 2018 | 28.19% |
| Mar 31, 2018 | -34.56% |
| Dec 31, 2017 | 155.65% |
| Sep 30, 2017 | -2,526.61% |
| Jun 30, 2017 | -106.15% |
| Mar 31, 2017 | 285.96% |
| Dec 31, 2016 | -731.48% |
| Sep 30, 2016 | -96.46% |
| Jun 30, 2016 | 347.19% |
| Mar 31, 2016 | -5,203.98% |